Serum lipids as an indicator for the alteration of liver function in patients with hepatitis B

Hepatitis B virus (HBV) exerts an intense impact on host lipid metabolism. Hence the aim of present study is to determine metabolic derangement that occurred in subjects suffering from hepatitis B patients. The fasting blood samples were collected from hepatitis B patients (n = 50) attended in Taluk...

Full description

Saved in:
Bibliographic Details
Published inLipids in health and disease Vol. 17; no. 1; pp. 36 - 10
Main Authors Arain, Sadia Qamar, Talpur, Farah Naz, Channa, Naseem Aslam, Ali, Muhammad Shahbaz, Afridi, Hassan Imran
Format Journal Article
LanguageEnglish
Published England BioMed Central Ltd 05.03.2018
BioMed Central
BMC
Subjects
Online AccessGet full text
ISSN1476-511X
1476-511X
DOI10.1186/s12944-018-0683-y

Cover

Loading…
Abstract Hepatitis B virus (HBV) exerts an intense impact on host lipid metabolism. Hence the aim of present study is to determine metabolic derangement that occurred in subjects suffering from hepatitis B patients. The fasting blood samples were collected from hepatitis B patients (n = 50) attended in Taluka hospital TandoAdam, Sindh with age and gender matched controls (n = 50). Serum lipid profile and fatty acid (FA) composition were analyzed by micro-lab and gas chromatography. The hepatitis B patients have significantly lower level (p < 0.01) of lipid profile including total cholesterol (TC), triacylglyceride (TAG), high density lipoprotein-C (HDL-C) very low density lipoprotein-cholesterol (VLDL-C), low density lipoprotein-cholesterol (LDL-C), and total lipid (TL) in comparison to controls, indicating hypolipidemia in patients. The result of total FA composition of HBV patients in comparison to controls reveal that myristic, palmitic, docosahexaenoic acids were significantly (p < 0.05) higher, while linoleic, eicosatrienoic, arachidonic, eicosapentaenoic acids were lower in HBV patients in comparison to controls. The elongase, ∆5 and ∆6-desaturase enzymes activities were found lower, while ∆9-desaturase activity was higher in hepatitis B patients as compared to controls, which indicates the impaired lipid metabolism. The serum saturated fatty acid (SFA) and monounsaturated fatty acid (MUFA) were increased while polyunsaturated fatty acid (PUFA) was reduced in both total and free form in hepatitis B patients due to altered activities of enzyme desaturases with impaired PUFA metabolism and non-enzymatic oxidation.
AbstractList Background Hepatitis B virus (HBV) exerts an intense impact on host lipid metabolism. Hence the aim of present study is to determine metabolic derangement that occurred in subjects suffering from hepatitis B patients. Methods The fasting blood samples were collected from hepatitis B patients (n = 50) attended in Taluka hospital TandoAdam, Sindh with age and gender matched controls (n = 50). Serum lipid profile and fatty acid (FA) composition were analyzed by micro-lab and gas chromatography. Results The hepatitis B patients have significantly lower level (p < 0.01) of lipid profile including total cholesterol (TC), triacylglyceride (TAG), high density lipoprotein-C (HDL-C) very low density lipoprotein-cholesterol (VLDL-C), low density lipoprotein-cholesterol (LDL-C), and total lipid (TL) in comparison to controls, indicating hypolipidemia in patients. The result of total FA composition of HBV patients in comparison to controls reveal that myristic, palmitic, docosahexaenoic acids were significantly (p < 0.05) higher, while linoleic, eicosatrienoic, arachidonic, eicosapentaenoic acids were lower in HBV patients in comparison to controls. The elongase, [DELA]5 and [DELA]6-desaturase enzymes activities were found lower, while [DELA]9-desaturase activity was higher in hepatitis B patients as compared to controls, which indicates the impaired lipid metabolism. Conclusion The serum saturated fatty acid (SFA) and monounsaturated fatty acid (MUFA) were increased while polyunsaturated fatty acid (PUFA) was reduced in both total and free form in hepatitis B patients due to altered activities of enzyme desaturases with impaired PUFA metabolism and non-enzymatic oxidation. Keywords: Hypolipidemia, GC-fid, Liver
Abstract Background Hepatitis B virus (HBV) exerts an intense impact on host lipid metabolism. Hence the aim of present study is to determine metabolic derangement that occurred in subjects suffering from hepatitis B patients. Methods The fasting blood samples were collected from hepatitis B patients (n = 50) attended in Taluka hospital TandoAdam, Sindh with age and gender matched controls (n = 50). Serum lipid profile and fatty acid (FA) composition were analyzed by micro-lab and gas chromatography. Results The hepatitis B patients have significantly lower level (p < 0.01) of lipid profile including total cholesterol (TC), triacylglyceride (TAG), high density lipoprotein-C (HDL-C) very low density lipoprotein-cholesterol (VLDL-C), low density lipoprotein-cholesterol (LDL-C), and total lipid (TL) in comparison to controls, indicating hypolipidemia in patients. The result of total FA composition of HBV patients in comparison to controls reveal that myristic, palmitic, docosahexaenoic acids were significantly (p < 0.05) higher, while linoleic, eicosatrienoic, arachidonic, eicosapentaenoic acids were lower in HBV patients in comparison to controls. The elongase, ∆5 and ∆6-desaturase enzymes activities were found lower, while ∆9-desaturase activity was higher in hepatitis B patients as compared to controls, which indicates the impaired lipid metabolism. Conclusion The serum saturated fatty acid (SFA) and monounsaturated fatty acid (MUFA) were increased while polyunsaturated fatty acid (PUFA) was reduced in both total and free form in hepatitis B patients due to altered activities of enzyme desaturases with impaired PUFA metabolism and non-enzymatic oxidation.
Hepatitis B virus (HBV) exerts an intense impact on host lipid metabolism. Hence the aim of present study is to determine metabolic derangement that occurred in subjects suffering from hepatitis B patients. The fasting blood samples were collected from hepatitis B patients (n = 50) attended in Taluka hospital TandoAdam, Sindh with age and gender matched controls (n = 50). Serum lipid profile and fatty acid (FA) composition were analyzed by micro-lab and gas chromatography. The hepatitis B patients have significantly lower level (p < 0.01) of lipid profile including total cholesterol (TC), triacylglyceride (TAG), high density lipoprotein-C (HDL-C) very low density lipoprotein-cholesterol (VLDL-C), low density lipoprotein-cholesterol (LDL-C), and total lipid (TL) in comparison to controls, indicating hypolipidemia in patients. The result of total FA composition of HBV patients in comparison to controls reveal that myristic, palmitic, docosahexaenoic acids were significantly (p < 0.05) higher, while linoleic, eicosatrienoic, arachidonic, eicosapentaenoic acids were lower in HBV patients in comparison to controls. The elongase, [DELA]5 and [DELA]6-desaturase enzymes activities were found lower, while [DELA]9-desaturase activity was higher in hepatitis B patients as compared to controls, which indicates the impaired lipid metabolism. The serum saturated fatty acid (SFA) and monounsaturated fatty acid (MUFA) were increased while polyunsaturated fatty acid (PUFA) was reduced in both total and free form in hepatitis B patients due to altered activities of enzyme desaturases with impaired PUFA metabolism and non-enzymatic oxidation.
Hepatitis B virus (HBV) exerts an intense impact on host lipid metabolism. Hence the aim of present study is to determine metabolic derangement that occurred in subjects suffering from hepatitis B patients.BACKGROUNDHepatitis B virus (HBV) exerts an intense impact on host lipid metabolism. Hence the aim of present study is to determine metabolic derangement that occurred in subjects suffering from hepatitis B patients.The fasting blood samples were collected from hepatitis B patients (n = 50) attended in Taluka hospital TandoAdam, Sindh with age and gender matched controls (n = 50). Serum lipid profile and fatty acid (FA) composition were analyzed by micro-lab and gas chromatography.METHODSThe fasting blood samples were collected from hepatitis B patients (n = 50) attended in Taluka hospital TandoAdam, Sindh with age and gender matched controls (n = 50). Serum lipid profile and fatty acid (FA) composition were analyzed by micro-lab and gas chromatography.The hepatitis B patients have significantly lower level (p < 0.01) of lipid profile including total cholesterol (TC), triacylglyceride (TAG), high density lipoprotein-C (HDL-C) very low density lipoprotein-cholesterol (VLDL-C), low density lipoprotein-cholesterol (LDL-C), and total lipid (TL) in comparison to controls, indicating hypolipidemia in patients. The result of total FA composition of HBV patients in comparison to controls reveal that myristic, palmitic, docosahexaenoic acids were significantly (p < 0.05) higher, while linoleic, eicosatrienoic, arachidonic, eicosapentaenoic acids were lower in HBV patients in comparison to controls. The elongase, ∆5 and ∆6-desaturase enzymes activities were found lower, while ∆9-desaturase activity was higher in hepatitis B patients as compared to controls, which indicates the impaired lipid metabolism.RESULTSThe hepatitis B patients have significantly lower level (p < 0.01) of lipid profile including total cholesterol (TC), triacylglyceride (TAG), high density lipoprotein-C (HDL-C) very low density lipoprotein-cholesterol (VLDL-C), low density lipoprotein-cholesterol (LDL-C), and total lipid (TL) in comparison to controls, indicating hypolipidemia in patients. The result of total FA composition of HBV patients in comparison to controls reveal that myristic, palmitic, docosahexaenoic acids were significantly (p < 0.05) higher, while linoleic, eicosatrienoic, arachidonic, eicosapentaenoic acids were lower in HBV patients in comparison to controls. The elongase, ∆5 and ∆6-desaturase enzymes activities were found lower, while ∆9-desaturase activity was higher in hepatitis B patients as compared to controls, which indicates the impaired lipid metabolism.The serum saturated fatty acid (SFA) and monounsaturated fatty acid (MUFA) were increased while polyunsaturated fatty acid (PUFA) was reduced in both total and free form in hepatitis B patients due to altered activities of enzyme desaturases with impaired PUFA metabolism and non-enzymatic oxidation.CONCLUSIONThe serum saturated fatty acid (SFA) and monounsaturated fatty acid (MUFA) were increased while polyunsaturated fatty acid (PUFA) was reduced in both total and free form in hepatitis B patients due to altered activities of enzyme desaturases with impaired PUFA metabolism and non-enzymatic oxidation.
Hepatitis B virus (HBV) exerts an intense impact on host lipid metabolism. Hence the aim of present study is to determine metabolic derangement that occurred in subjects suffering from hepatitis B patients. The fasting blood samples were collected from hepatitis B patients (n = 50) attended in Taluka hospital TandoAdam, Sindh with age and gender matched controls (n = 50). Serum lipid profile and fatty acid (FA) composition were analyzed by micro-lab and gas chromatography. The hepatitis B patients have significantly lower level (p < 0.01) of lipid profile including total cholesterol (TC), triacylglyceride (TAG), high density lipoprotein-C (HDL-C) very low density lipoprotein-cholesterol (VLDL-C), low density lipoprotein-cholesterol (LDL-C), and total lipid (TL) in comparison to controls, indicating hypolipidemia in patients. The result of total FA composition of HBV patients in comparison to controls reveal that myristic, palmitic, docosahexaenoic acids were significantly (p < 0.05) higher, while linoleic, eicosatrienoic, arachidonic, eicosapentaenoic acids were lower in HBV patients in comparison to controls. The elongase, ∆5 and ∆6-desaturase enzymes activities were found lower, while ∆9-desaturase activity was higher in hepatitis B patients as compared to controls, which indicates the impaired lipid metabolism. The serum saturated fatty acid (SFA) and monounsaturated fatty acid (MUFA) were increased while polyunsaturated fatty acid (PUFA) was reduced in both total and free form in hepatitis B patients due to altered activities of enzyme desaturases with impaired PUFA metabolism and non-enzymatic oxidation.
ArticleNumber 36
Audience Academic
Author Talpur, Farah Naz
Channa, Naseem Aslam
Ali, Muhammad Shahbaz
Afridi, Hassan Imran
Arain, Sadia Qamar
Author_xml – sequence: 1
  givenname: Sadia Qamar
  surname: Arain
  fullname: Arain, Sadia Qamar
– sequence: 2
  givenname: Farah Naz
  surname: Talpur
  fullname: Talpur, Farah Naz
– sequence: 3
  givenname: Naseem Aslam
  surname: Channa
  fullname: Channa, Naseem Aslam
– sequence: 4
  givenname: Muhammad Shahbaz
  surname: Ali
  fullname: Ali, Muhammad Shahbaz
– sequence: 5
  givenname: Hassan Imran
  surname: Afridi
  fullname: Afridi, Hassan Imran
BackLink https://www.ncbi.nlm.nih.gov/pubmed/29506525$$D View this record in MEDLINE/PubMed
BookMark eNp1kktv1DAUhSNURB_wA9igSGzYpMRO_NogtRWPSpVYABIrrBvHnnGVsQfbUzT_njuTFnUQKInsnHvup2v5nFZHIQZbVS9Je06I5G8zoarvm5bIpuWya7ZPqhPSC94wQr4fPdofV6c537YtbQXnz6pjqljLGWUn1Y8vNm1W9eTXfsw14BtqH0ZvoMRUO_zK0tYwFZug-Bjq6NB8Z7G2CWav-FCvsWZDyfUvX5b10u7-i8_15fPqqYMp2xf361n17cP7r1efmpvPH6-vLm4awzpaGunAEaIcYa4zjjEnBKBmUGbUuoEIA4rjnkjmiBoUoUxQUASUBNHR7qy6nrljhFu9Tn4FaasjeL0XYlpoSMWbyWpOBPTMMgkj7-3YyWGkrBeO9gMoq0ZkvZtZ682wsqPBgyWYDqCHleCXehHvNJOdlLxDwJt7QIo_NzYXvfLZ2GmCYOMma9oSQoXo5G7u17N1ATiaDy4i0ezs-oL1vJWKU4mu83-48BntyhvMhPOoHzS8enyEP7M_3DsaxGwwKeacrNPGl_0FI9lPmrR6lzA9J0xjwvQuYXqLneSvzgf4_3t-Azgb0_w
CitedBy_id crossref_primary_10_1186_s12944_023_01826_y
crossref_primary_10_1016_j_cyto_2020_155189
crossref_primary_10_3389_fmicb_2021_636897
crossref_primary_10_1016_j_pdpdt_2022_102808
crossref_primary_10_1186_s12944_025_02434_8
crossref_primary_10_1111_1751_7915_14303
crossref_primary_10_1186_s13104_021_05474_2
crossref_primary_10_1007_s10552_024_01853_9
crossref_primary_10_1016_j_jhep_2022_02_016
crossref_primary_10_1016_j_jprot_2024_105358
crossref_primary_10_1016_j_prostaglandins_2020_106484
crossref_primary_10_1016_j_pdpdt_2021_102386
crossref_primary_10_1016_j_jtumed_2023_01_002
crossref_primary_10_1016_j_jhepr_2022_100479
crossref_primary_10_1021_acs_jproteome_4c00747
crossref_primary_10_1042_BSR20211769
Cites_doi 10.7555/JBR.26.20120058
10.1007/s13197-012-0677-0
10.1111/jgh.12700
10.1002/hep.23229
10.3164/jcbn.12-79
10.1016/j.redox.2016.09.002
10.1016/j.jhep.2010.07.039
10.1074/jbc.M108413200
10.1002/hep.20283
10.1186/1476-511X-12-25
10.1186/s12944-017-0437-2
10.1038/oby.2009.379
10.1146/annurev.physiol.65.092101.142622
10.4062/biomolther.2014.017
10.1016/j.cbpb.2014.06.005
10.1016/B978-012373947-6.00685-1
10.4103/2348-3334.201981
10.1503/cmaj.1030034
10.1111/j.1462-5822.2008.01250.x
10.1111/j.1440-1746.2009.06154.x
10.3748/wjg.v22.i4.1664
10.1074/jbc.M510660200
10.3748/wjg.14.6546
10.1189/jlb.71.1.16
10.1016/S0022-2275(20)31527-3
10.1194/jlr.E033407
10.1194/jlr.M800123-JLR200
10.3390/nu5104093
10.3748/wjg.v20.i33.11595
10.1002/hep.22183
10.5772/51204
10.1097/MD.0000000000003609
10.1093/ijnp/pyx089
10.3390/nu3010152
ContentType Journal Article
Copyright COPYRIGHT 2018 BioMed Central Ltd.
The Author(s). 2018
Copyright_xml – notice: COPYRIGHT 2018 BioMed Central Ltd.
– notice: The Author(s). 2018
DBID AAYXX
CITATION
NPM
7X8
5PM
DOA
DOI 10.1186/s12944-018-0683-y
DatabaseName CrossRef
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList


MEDLINE - Academic
PubMed
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Anatomy & Physiology
EISSN 1476-511X
EndPage 10
ExternalDocumentID oai_doaj_org_article_617a45e58ad64ed38bd2547f24ba9e9d
PMC5838863
A546089628
29506525
10_1186_s12944_018_0683_y
Genre Journal Article
GroupedDBID ---
0R~
29L
2WC
53G
5GY
5VS
7X7
88E
8FE
8FH
8FI
8FJ
A8Z
AAFWJ
AAHBH
AAJSJ
AASML
AAYXX
ABDBF
ABUWG
ACGFO
ACGFS
ACPRK
ACUHS
ADBBV
ADRAZ
ADUKV
AENEX
AFKRA
AFPKN
AHBYD
AHMBA
AHYZX
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
BAPOH
BAWUL
BBNVY
BCNDV
BENPR
BFQNJ
BHPHI
BMC
BPHCQ
BVXVI
C6C
CCPQU
CITATION
CS3
DIK
E3Z
EAD
EAP
EAS
EBD
EBLON
EBS
EJD
EMB
EMK
EMOBN
ESX
F5P
FYUFA
GROUPED_DOAJ
GX1
H13
HCIFZ
HH5
HMCUK
HYE
IAO
IGS
IHR
INH
INR
ITC
KQ8
LK8
M1P
M48
M7P
M~E
O5R
O5S
OK1
OVT
P2P
P6G
PGMZT
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
RBZ
RNS
ROL
RPM
RSV
SBL
SOJ
SV3
TR2
TUS
U2A
UKHRP
W2D
WOQ
WOW
XSB
NPM
PJZUB
PPXIY
PQGLB
PMFND
7X8
5PM
PUEGO
ID FETCH-LOGICAL-c532t-8faf119f15f3cf55f77a8facfaf52efb17ca96f52185f19b912572a91a98a7323
IEDL.DBID M48
ISSN 1476-511X
IngestDate Wed Aug 27 01:07:15 EDT 2025
Thu Aug 21 18:15:31 EDT 2025
Fri Jul 11 12:06:33 EDT 2025
Tue Jun 17 21:35:41 EDT 2025
Tue Jun 10 20:14:10 EDT 2025
Mon Jul 21 05:46:45 EDT 2025
Thu Apr 24 22:58:31 EDT 2025
Tue Jul 01 00:23:10 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Hypolipidemia
Liver
GC-fid
Language English
License Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c532t-8faf119f15f3cf55f77a8facfaf52efb17ca96f52185f19b912572a91a98a7323
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.1186/s12944-018-0683-y
PMID 29506525
PQID 2011277382
PQPubID 23479
PageCount 10
ParticipantIDs doaj_primary_oai_doaj_org_article_617a45e58ad64ed38bd2547f24ba9e9d
pubmedcentral_primary_oai_pubmedcentral_nih_gov_5838863
proquest_miscellaneous_2011277382
gale_infotracmisc_A546089628
gale_infotracacademiconefile_A546089628
pubmed_primary_29506525
crossref_citationtrail_10_1186_s12944_018_0683_y
crossref_primary_10_1186_s12944_018_0683_y
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2018-03-05
PublicationDateYYYYMMDD 2018-03-05
PublicationDate_xml – month: 03
  year: 2018
  text: 2018-03-05
  day: 05
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
PublicationTitle Lipids in health and disease
PublicationTitleAlternate Lipids Health Dis
PublicationYear 2018
Publisher BioMed Central Ltd
BioMed Central
BMC
Publisher_xml – name: BioMed Central Ltd
– name: BioMed Central
– name: BMC
References 683_CR7
683_CR22
C Niederau (683_CR19) 2014; 20
683_CR6
683_CR41
KE Bradbury (683_CR23) 2011; 3
J Araya (683_CR32) 2010; 18
AE Feldstein (683_CR38) 2004; 40
W Wu (683_CR40) 2010; 25
683_CR1
H Miyoshi (683_CR4) 2011; 54
S Ferdinandusse (683_CR35) 2001; 42
X Xue (683_CR26) 2014; 175
CC Wang (683_CR21) 2015; 30
RH Unger (683_CR9) 2003; 65
JK Kwarteng (683_CR5) 2012; 32
N Kaur (683_CR31) 2014; 51
S Noorali (683_CR2) 2008; 2
683_CR33
D Ristic-Medic (683_CR34) 2013; 53
RG Gray (683_CR12) 2013; 12
YA Moon (683_CR24) 2001; 276
P Puri (683_CR25) 2009; 50
CJ Field (683_CR16) 2002; 71
Z Li (683_CR39) 2008; 47
A Agbecha (683_CR18) 2017; 4
BA Conlon (683_CR8) 2013; 5
YA Carpentier (683_CR10) 2008; 22
683_CR30
SQ Arain (683_CR11) 2015; 6
CM Bremer (683_CR15) 2009; 11
KR Feingold (683_CR17) 2012; 53
Y Wang (683_CR27) 2008; 49
M Jiang (683_CR13) 2008; 14
T Sassa (683_CR28) 2014; 22
SQ Arain (683_CR36) 2015; 14
C Ress (683_CR3) 2016; 22
683_CR29
T Wong (683_CR20) 2006; 174
H Malhi (683_CR37) 2006; 281
SQ Arain (683_CR14) 2017; 16
References_xml – ident: 683_CR41
  doi: 10.7555/JBR.26.20120058
– volume: 32
  start-page: 1
  issue: 3
  year: 2012
  ident: 683_CR5
  publication-title: J Sci Technol
– volume: 51
  start-page: 2289
  issue: 10
  year: 2014
  ident: 683_CR31
  publication-title: J Food Sci Technol
  doi: 10.1007/s13197-012-0677-0
– volume: 30
  start-page: 14
  issue: 1
  year: 2015
  ident: 683_CR21
  publication-title: J Gastroenterol Hepatol
  doi: 10.1111/jgh.12700
– volume: 50
  start-page: 1827
  issue: 6
  year: 2009
  ident: 683_CR25
  publication-title: Hepatol
  doi: 10.1002/hep.23229
– volume: 53
  start-page: 49
  issue: 1
  year: 2013
  ident: 683_CR34
  publication-title: J Clin Biochem Nutr
  doi: 10.3164/jcbn.12-79
– ident: 683_CR7
  doi: 10.1016/j.redox.2016.09.002
– volume: 54
  start-page: 432
  issue: 3
  year: 2011
  ident: 683_CR4
  publication-title: J Hepatol
  doi: 10.1016/j.jhep.2010.07.039
– volume: 276
  start-page: 45358
  issue: 48
  year: 2001
  ident: 683_CR24
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M108413200
– volume: 40
  start-page: 185
  issue: 1
  year: 2004
  ident: 683_CR38
  publication-title: Hepatol
  doi: 10.1002/hep.20283
– volume: 12
  start-page: 25
  issue: 1
  year: 2013
  ident: 683_CR12
  publication-title: Lipids Health Dis
  doi: 10.1186/1476-511X-12-25
– volume: 16
  start-page: 51
  issue: 1
  year: 2017
  ident: 683_CR14
  publication-title: Lipids Health Dis
  doi: 10.1186/s12944-017-0437-2
– volume: 18
  start-page: 1460
  issue: 7
  year: 2010
  ident: 683_CR32
  publication-title: Obesity
  doi: 10.1038/oby.2009.379
– volume: 65
  start-page: 333
  issue: 1
  year: 2003
  ident: 683_CR9
  publication-title: Annu Rev Physiol
  doi: 10.1146/annurev.physiol.65.092101.142622
– volume: 22
  start-page: 83
  issue: 2
  year: 2014
  ident: 683_CR28
  publication-title: Biomol Ther
  doi: 10.4062/biomolther.2014.017
– volume: 175
  start-page: 9
  year: 2014
  ident: 683_CR26
  publication-title: Comp Biochem Physiol B: Biochem Mol Biol
  doi: 10.1016/j.cbpb.2014.06.005
– ident: 683_CR33
  doi: 10.1016/B978-012373947-6.00685-1
– volume: 2
  start-page: 373
  issue: 5
  year: 2008
  ident: 683_CR2
  publication-title: J Infect Dev Ctries
– volume: 4
  start-page: 81
  issue: 2
  year: 2017
  ident: 683_CR18
  publication-title: CHRISMED J Health Res
  doi: 10.4103/2348-3334.201981
– volume: 174
  start-page: 649
  issue: 5
  year: 2006
  ident: 683_CR20
  publication-title: CMAJ
  doi: 10.1503/cmaj.1030034
– ident: 683_CR6
– volume: 11
  start-page: 249
  issue: 2
  year: 2009
  ident: 683_CR15
  publication-title: Cell Microbiol
  doi: 10.1111/j.1462-5822.2008.01250.x
– volume: 25
  start-page: 750
  year: 2010
  ident: 683_CR40
  publication-title: J Gastroenterol Hepatol
  doi: 10.1111/j.1440-1746.2009.06154.x
– volume: 22
  start-page: 1664
  issue: 4
  year: 2016
  ident: 683_CR3
  publication-title: World J Gastroenterol
  doi: 10.3748/wjg.v22.i4.1664
– volume: 22
  start-page: 255
  issue: 2
  year: 2008
  ident: 683_CR10
  publication-title: Int J Mol Med
– volume: 281
  start-page: 12093
  issue: 17
  year: 2006
  ident: 683_CR37
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M510660200
– volume: 14
  start-page: 6546
  issue: 42
  year: 2008
  ident: 683_CR13
  publication-title: World J Gastroenterol: WJG
  doi: 10.3748/wjg.14.6546
– volume: 71
  start-page: 16
  issue: 1
  year: 2002
  ident: 683_CR16
  publication-title: J Leukoc Biol
  doi: 10.1189/jlb.71.1.16
– volume: 42
  start-page: 1987
  issue: 12
  year: 2001
  ident: 683_CR35
  publication-title: J Lipid Res
  doi: 10.1016/S0022-2275(20)31527-3
– volume: 53
  start-page: 2487
  issue: 12
  year: 2012
  ident: 683_CR17
  publication-title: J Lipid Res
  doi: 10.1194/jlr.E033407
– volume: 49
  start-page: 1538
  issue: 7
  year: 2008
  ident: 683_CR27
  publication-title: J Lipid Res
  doi: 10.1194/jlr.M800123-JLR200
– volume: 5
  start-page: 4093
  issue: 10
  year: 2013
  ident: 683_CR8
  publication-title: Nutrients
  doi: 10.3390/nu5104093
– volume: 20
  start-page: 11595
  issue: 33
  year: 2014
  ident: 683_CR19
  publication-title: WJG
  doi: 10.3748/wjg.v20.i33.11595
– volume: 14
  start-page: 1
  issue: 117
  year: 2015
  ident: 683_CR36
  publication-title: BMC Lipids Health Dis
– volume: 47
  start-page: 1495
  year: 2008
  ident: 683_CR39
  publication-title: Hepatol
  doi: 10.1002/hep.22183
– ident: 683_CR30
  doi: 10.5772/51204
– ident: 683_CR22
  doi: 10.1097/MD.0000000000003609
– ident: 683_CR29
  doi: 10.1093/ijnp/pyx089
– ident: 683_CR1
– volume: 6
  start-page: 37
  year: 2015
  ident: 683_CR11
  publication-title: IJBRR
– volume: 3
  start-page: 152
  issue: 1
  year: 2011
  ident: 683_CR23
  publication-title: Nutrients
  doi: 10.3390/nu3010152
SSID ssj0020766
Score 2.2844381
Snippet Hepatitis B virus (HBV) exerts an intense impact on host lipid metabolism. Hence the aim of present study is to determine metabolic derangement that occurred...
Background Hepatitis B virus (HBV) exerts an intense impact on host lipid metabolism. Hence the aim of present study is to determine metabolic derangement that...
Abstract Background Hepatitis B virus (HBV) exerts an intense impact on host lipid metabolism. Hence the aim of present study is to determine metabolic...
SourceID doaj
pubmedcentral
proquest
gale
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 36
SubjectTerms Diagnosis
GC-fid
Health aspects
Hepatitis B
Hypolipidemia
Lipids
Liver
Liver function tests
Methods
Physiological aspects
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1La9wwEBYlh9BLaZM-3CZFhdJCwcSSrddxUxpCIT01kFOFJEvEkHhDvHvYf98Z2busKbSXgg-2NAZZM6OZ0Yw_EfLRsRBixWKZ6pqXjTOh9MrzkjlfRalMpT3ud1z9kJfXzfcbcbN31BfWhI3wwOPEnYGFdY2IQrtWNrGttW8hplGJN96ZaFpcfcHmbYOpKdSC6FxOOUym5dkAVq3BaguNh6zU5WZmhTJY_59L8p5NmtdL7hmgi-fk2eQ50sU44hfkSeyPyPGih6j5fkM_0VzLmTfJj8jh1ZQyPya_YDVY39O77qFrB-rg6inmqQNG2xRcVgouIM1J88wkukxADAJO0eTllq6nE_zqQHHflt5GfF51Az1_Sa4vvv38ellOhyqUQdR8VerkEmMmMZHqkIRISjloC9AseEyeqeCMhHsw5IkZb8ADUtwZ5ox2qub1K3LQL_v4hlATqyCdSDHx0HhWuZY5pyrpEEM_BV-QajvJNkyI43jwxZ3NkYeWduSLBb5Y5IvdFOTL7pWHEW7jb8TnyLkdISJl5waQHzvJj_2X_BTkM_Ldoj7D4IKbfkuAT0RkLLsQjay0kVwX5GRGCXoYZt0ftpJjsQuL1_q4XA8WfSyuVK15QV6PkrQbMzcCnEAuCqJmMjb7qHlP391mGHBMeGtZv_0fs_COPOVZO7CY84QcrB7X8RS8rZV_nxXrNyEKKRs
  priority: 102
  providerName: Directory of Open Access Journals
Title Serum lipids as an indicator for the alteration of liver function in patients with hepatitis B
URI https://www.ncbi.nlm.nih.gov/pubmed/29506525
https://www.proquest.com/docview/2011277382
https://pubmed.ncbi.nlm.nih.gov/PMC5838863
https://doaj.org/article/617a45e58ad64ed38bd2547f24ba9e9d
Volume 17
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3di9QwEA_3AeKL6J0f1XOJIApCtU3bfDyI7Modh7CHiAv7ZEjTxCvsdc_tLrj_vTPZ7rLFU-hDm6SlzcxkZjLT3xDy2qTWuiR1sc8yFudG2bgUJYtTUyaOC5XIEvc7xlf8cpJ_mRbTA7Itb9VNYHuna4f1pCaL2fvfv9afQOA_BoGX_EMLOivHXAqJJVSyeH1IjkExCZTTcb4LKjBw2XkX2LzzNgQGVgXoZKybvaelApj_30v2ns7q51PuKaiLh-RBZ1nS4YYVHpED15yQ02EDXvXNmr6hIdczbKKfkHvjLqR-Sn7AarG6obP6tq5aauBoKMaxLXrjFExaCiYiDUH1QEQ69zAYBICiSgwtdUM7eNaW4r4uvXZ4vaxbOnpMJhfn3z9fxl3RhdgWGVvG0hufpsqnhc-sLwovhIE2C80Fc75MhTWKwzkoep-qUoGFJJhRqVHSiIxlT8hRM2_cM0KVSyw3hXee2bxME1OlxoiEG8TY97aMSLKdZG07RHIsjDHTwTORXG9IpIFEGkmk1xF5t7vldgPH8b_BI6TcbiAiaYeG-eKn7gRTgwVn8sIV0lQ8d1Umywp8ZuFZXhrlVBWRt0h3jRwIL2dN99sCfCIiZ-lhkfNEKs5kRM56I0FOba_71ZZzNHZhclvj5qtWow3GhMgki8jTDSft3nnLkBERPR7rfVS_p6mvA0w4BsQlz57_85kvyH0WuB8zOM_I0XKxci_BxFqWA3IopmJAjkfnV1-_DcJGxSAI0x9omyaZ
linkProvider Scholars Portal
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Serum+lipids+as+an+indicator+for+the+alteration+of+liver+function+in+patients+with+hepatitis+B&rft.jtitle=Lipids+in+health+and+disease&rft.au=Arain%2C+Sadia+Qamar&rft.au=Talpur%2C+Farah+Naz&rft.au=Channa%2C+Naseem+Aslam&rft.au=Ali%2C+Muhammad+Shahbaz&rft.date=2018-03-05&rft.eissn=1476-511X&rft.volume=17&rft.issue=1&rft.spage=36&rft_id=info:doi/10.1186%2Fs12944-018-0683-y&rft_id=info%3Apmid%2F29506525&rft.externalDocID=29506525
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1476-511X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1476-511X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1476-511X&client=summon